1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
MDU Resources increased its board to nine directors and elected Charles M. Kelley and Tammy J. Miller, both effective August 12, 2025, to serve until the 2026 Annual Meeting. Both were also appointed to the Audit Committee, and the board determined that both are independent under NYSE listing standards.
Board size increased to nine directors; Kelley and Miller elected August 12, 2025, effective immediately
Both will serve until the 2026 Annual Meeting of Stockholders and are on the Audit Committee
Kelley spent a 25-year career at ONEOK, most recently as senior vice president of Natural Gas Pipelines
Miller is a former lieutenant governor of North Dakota and former CEO and board chair of Border States
MSA Safety Incorporated appointed Julie A. Beck as Senior Vice President, Chief Financial Officer and Treasurer, effective August 18, 2025, succeeding interim CFO Elyse Brody, who will return to her role as Executive Director of Financial Planning and Analysis and Strategy. Beck was previously CFO of Terex Corporation from November 2021 to February 2025. The filing discloses a restricted stock unit award with a $250,000 grant date value but no financial results.
Julie A. Beck, 63, becomes SVP, CFO and Treasurer effective August 18, 2025
Beck was CFO of Terex Corporation from November 2021 to February 2025 and CFO of Nova Chemicals from February 2016 to September 2021
Beck receives restricted stock units with a $250,000 grant date value, vesting one-third per year over three years
Elyse L. Brody ends her interim CFO role and remains Executive Director of Financial Planning and Analysis and Strategy
Brink's said Executive Vice President and President, North America Daniel J. Castillo resigned, effective August 29, 2025, to pursue another opportunity. The filing does not name a successor or describe any financial impact, so the change's effect on shareholders is not stated.
Daniel J. Castillo, EVP and President, North America, notified the company of his resignation on August 8, 2025.
Resignation takes effect August 29, 2025.
He is leaving to pursue another opportunity; no successor is named in the filing.
Sarepta Therapeutics said Bilal Arif, its Executive Vice President and Chief Technical Operations Officer until August 12, 2025, will leave the company as part of a strategic restructuring and pipeline prioritization. He will serve as a consultant through December 31, 2025, and the filing gives a $576,700 severance payment and a $400 hourly consulting fee.
Employment ends effective September 16, 2025; Arif serves as Special Advisor to the President until then
Separation and Consulting Agreement dated August 12, 2025, with consulting through December 31, 2025
Severance lump sum of $576,700 and consulting fee of $400 per hour
Outstanding equity awards as of August 12, 2025 continue to vest during his employment or consulting period
Chairman I. Martin Inglis will retire from the board and not stand for re-election at the 2025 Annual Meeting, which is currently expected on October 7, 2025. CEO Tony R. Thene will become chairman while continuing as CEO, and Chief Operating Officer Brian J. Malloy will become president and chief operating officer, changes that set the company's leadership structure for the coming year.
I. Martin Inglis, chairman since 2021 and a director since 2003, will not stand for re-election; the filing says his decision is not due to any disagreement with the company or board
Tony R. Thene, President and CEO, will be chairman of the board and remain CEO, effective immediately before the 2025 Annual Meeting
Brian J. Malloy, Senior Vice President and COO, will become President and COO; Steven M. Ward becomes Lead Independent Director
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.